Contract HHSN272201300855P
Medigen, Inc. · Department Of Health And Human Services · August 15, 2013
Medigen, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on August 15, 2013 for $40,000 of work in research and development in biotechnology. Performance is in Frederick, MD. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- HHSN272201300855P
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- Medical- Laboratory Testing
- Place of performance
- Frederick, MD
- First action
- August 15, 2013
Description
IGF::OT::IGF AMBIS #1635093 - PREPARATION OF HIGH-TITER BACULOVIRUS STOCK AND VLP EXPRESSION TEST.
Modification timeline
-
August 15, 2013Base award$40.2K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| University Of Illinois | Department Of Health And Human Services | March 26, 2026 | $2.27M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 25, 2026 | $9.65M |
| University Of Texas Medical Branch At Galveston | Department Of Health And Human Services | March 23, 2026 | $1.61M |
| Regeneron Pharmaceuticals Inc | Department Of Health And Human Services | March 19, 2026 | $8.60M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.23M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.22M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Alliance For Energy Innovation, Llc | 2 | $10.68B |
| 2 | Emergent Product Development Gaithersburg Inc. | 7 | $1.63B |
| 3 | Janssen Pharmaceuticals, Inc. | 2 | $1.05B |
| 4 | Regeneron Pharmaceuticals Inc | 4 | $1.01B |
| 5 | Siga Technologies, Inc. | 3 | $560.59M |
| 6 | Battelle National Biodefense Institute, Llc | 106 | $469.31M |
| 7 | Glaxosmithkline, Llc | 6 | $321.65M |
| 8 | Merck Sharp & Dohme Llc | 3 | $309.72M |
| 9 | Sri International | 130 | $258.61M |
| 10 | American Type Culture Collection | 7 | $243.18M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSN272201300855P?
Contract HHSN272201300855P is a federal contract awarded to Medigen, Inc. by Department Of Health And Human Services on August 15, 2013 for $40,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 0 times since the base award.
Who won contract HHSN272201300855P?
Medigen, Inc. won contract HHSN272201300855P from Department Of Health And Human Services.
How much is contract HHSN272201300855P worth?
Contract HHSN272201300855P has obligated $40,000 to date.